The present invention provides compounds of formula (I):
wherein all variables are as defined herein, pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.
The synthesis and biological activities of imidazo[5,1-f][1,2,4]triazin-2-amines (imidazotriazines) as novel polo-like kinase 1 inhibitors are reported.
IMIDAZOTRIAZINE COMPOUNDS
申请人:SMITHKLINE BEECHAM CORPORATION
公开号:EP1608656A2
公开(公告)日:2005-12-28
IMIDAZOTRIAZINE COMPOUNDS FOR THE TREATMENT OF CANCER DISEASES